Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Shinya Goto: Country Specific Randomized Trial Show the Merit of DOAC in Intermediate Risk of A
Sep 15, 2026, 01:58

Shinya Goto: Country Specific Randomized Trial Show the Merit of DOAC in Intermediate Risk of A

Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article by Daehoon Kim et al., published in The New England Journal of Medicine, adding:

“Country specific randomized trial show the merit of DOAC in intermediate risk of A”

Title: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk

Authors: Daehoon Kim, Young Soo Lee, Jaemin Shim, Hee Tae Yu, Junbeom Park, Jin-Kyu Park, Il-Young Oh, Ki-Woon Kang, Eue-Keun Choi, Kyoung-Min Park, Hyoung-Seob Park, Dae-Hyeok Kim, Hyung Wook Park, Jun Kim, Jum-Suk Ko, Dongmin Kim, Jong-Youn Kim, Jin-Bae Kim, Jung-Hoon Sung, Tae-Hoon Kim, Jae-Sun Uhm, Hui-Nam Pak, Boyoung Joung

Shinya Goto

Other posts featuring Shinya Goto on Hemostasis Today.